支原体测试市场Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Kits & Reagents, Services); By Technology (PCR, ELISA, Direct Assay, Indirect Assay, Microbial Culture Techniques, Enzymatic Methods); By Application; By End Use; By Regions; Segment Forecast, 2020 - 2027

Report Summary

全球支原体测试市场于2019年的628.2百万美元估价，预计预测期内的CAGR增长率为12.8％。增加细胞培养污染情况，对研发的投资以及关键市场参与者的新技术引入是负责市场增长的突出因素。

To overcome, the shortcomings in the currently employed cell culture systems, innovators in the market have developed more rapid and accurate mycoplasma testing systems. One such system includes Nucleic Acid-based Technology (NAT), introduced by American Type Culture Collection, which allows mycoplasma detection in cell culture within minutes.

Know more about this report:请求样本页面

行业动态

增长司机
通过制药公司提高市场的研究活动导致采用较新技术的药物开发程序。主要公司的重大投资增强了支原体测试市场增长。例如，在2018年，Boehringer宣布投资超过25900万美元，在其位于德国的研发网站上建立新的生物学开发中心（BDC）。默克还计划为其研发活动投资为160亿美元。这些巨大的研发支出被预计扩大到显着的发展，提高了支原体测试产品和服务的销售。必威开户注册

Moreover, research activities in the market in both biotechnology and pharma sectors are largely supported by several government organizations. For instance, in April 2019, the Food and Drug Administration (FDA), announced the amendment in regulations pertaining to the testing methods in the mycoplasma contaminations. With such amendments, the stakeholders would employ protective measures for possible mycoplasma contaminations. Thus, an increase in government funding towards research and development activities fostering the uptake in mycoplasma testing products.

支原体测试市场报告范围

该市场主要是在产品，技术，应用，最终用途和地区的基础上进行分段。

By Product	通过技术	By Application	By Region
仪器 套件和试剂 PCR测定 核酸检测试剂盒 污渍 Elimination Kits Standards & Controls 其他 必威开户注册	PCR. 埃莉莎 直接试验 Indirect Assay Microbial Culture Techniques Enzymatic Methods	细胞系测试 Virus Testing End of Production Cells Testing 其他	North America (U.S., Canada) Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) 亚太（日本，中国，印度，马来西亚，印度尼西亚，韩国） Latin America (Brazil, Mexico, Argentina) Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Know more about this report:请求样本页面

产品洞察力

On the basis of product, the global mycoplasma testing industry is bifurcated into instruments, reagents, and services. In 2019, the kits segment accounted for the largest revenue share. The continuous use of consumables in mycoplasma detection in research and other applications is primarily responsible for such market segment growth. PCR assays are the most accurate detection techniques, using gel electrophoresis, by verifying different bands of DNA fragments. For instance, Japan-based company, Takara Bio Inc. has introduced PCR mycoplasma sets to contain contamination in the cultured cells from different cell lines.

仪器market segment expected to register a lucrative growth rate over the study period. The growing availability of automated systems in the market is responsible for such high market segment growth. For instance, Bio-Rad laboratories have developed a PCR-based CFX96 Touch PCR Detection System. This is a flexible PCR kit with advanced optical technology, which can deliver reliable service for both multiplex and singleplex reactions.

Insight by Application

2019年，由于研究活动的数量，它在2019年测试市场分部占最大的份额cell culture. Cell line testing is extremely useful in the pharmaceutical industry. The end of production cell testing market segment is projected to exhibit a lucrative market growth over the forecast period.

越来越多的临床试验of drug discovery and cell harvesting technology is primarily responsible for the growth of mycoplasma testing market. It involves mRNA sequencing, Southern Blotting, and genetic analysis using transgenes. Thereby, quality control measures involved during drug discovery are the major factor inducing such market growth.

Insight by Technology

基于该技术，全球支原体检测行业分叉进入PCR，ELISA，直接测定，间接测定，微生物培养技术和酶法。2019年，PCR市场分部占最大份额。PCR能够检测具有高特异性和效率的多种支原体物种。其快速的检测能力和用户友好性是这种技术提供的主要优点。例如，监视Mycoplasma PCR，由Merck开发，促进了细胞培养物中的遗传症，脑卒中和支原体污染。

直接测定预计在研究期间展示了显着的市场增长率。由于其高级别确定性的快速采用是支原体测试行业增长的主要原因。此外，对药业行业的污染和其他研究活动对微生物培养的高需求也有利于市场部门的增长前景。

地理概述

地理上，全球支原体测试行业被分叉进入北美，亚太地区，欧洲，拉丁美洲和中东和非洲。2019年，由于美国的研究机构和更高的医疗保健支出，促进药物空间中的研究活动，北美的支原体测试行业占最大的收入份额，而且由于美国的研究机构和更高的医疗保健支出。betway体育亚洲版入口根据国家科学基金会的估计，2019年，美国的研发活动表现出积极的趋势。

亚太地区支原体检测行业预计会在研究期间表现出利润丰厚的增长率。这一预计的增长是由于印度等国家的积极资金场景和重大意识。印度政府推出了几种战略举措，以促进更大规模的研发活动。此外，还预计生物安全级别指南的监管政策也将在长期内创造机会。

Competitive Insight

The prominent players operating in the market include Thermo Fisher Scientific, Inc., Bionique Testing Laboratories, Inc., Lonza Group Ltd., Merck KGaA, Roche Diagnostics, Meridian Bioscience, Inc., Charles River Laboratories International, Inc., Savyon Diagnostics, American Type Culture Collection, InvivoGen, PromoCell GmbH.

Few other market players in the industry include Nelson Laboratories Fairfield, Inc., Creative Bioarray, Mycoplasma Experience, Biological Industries Israel Beit Haemek Ltd., Norgen Biotek Corp., Biotools B & M Labs, S.A., GeneCopoeia, Inc., GenBio, Minerva Biolabs GmbH, Sartorius AG, Clongen Laboratories, Inc., and ScienCell Research Laboratories, Inc.